Stay updated with breaking news from Upstream Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In addition to recent Independence Day festivities, the U.S. biotech space has other reasons to celebrate. The asthma drug developer Upstream Bio topped the ranks for the U.S.’ biggest early-stage biotech investment in June 2022, but manufacturing heavyweight National Resilience, Inc. bagged the private funding top spot with a huge Series D round.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
More than 500 people are expected to attend the weekend-long event that will bring together global experts, public policy leaders, students, faculty, and alumni for weekend of provocative discussions, a new facility dedication, and community celebrations, all focused on innovation, collaboration, and the art of the possible.
HBM Healthcare Investments AG / Key word(s): Quarter Results HBM Healthcare Investments Quarterly Report December 2021 21-Jan-2022 / 06:46 CE...